Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 2
2005 3
2006 4
2007 4
2008 3
2009 2
2010 1
2012 2
2013 8
2014 9
2015 1
2016 17
2017 10
2018 11
2019 8
2020 13
2021 20
2022 24
2023 20
2024 18
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Quelle place pour l’automatisation intelligente et l’intelligence artificielle pour préserver et renforcer l’expertise en vigilance devant l’augmentation des déclarations ?
Pariente A, Micallef J, Lahouegue A, Molimard M, Auffret M, Chouchana L, Denis B, Faillie JL, Grandvuillemin A, Letinier L, Pierron E, Pons C, Pujade I, Rubino H, Salvo F. Pariente A, et al. Among authors: salvo f. Therapie. 2023 Jan-Feb;78(1):115-129. doi: 10.1016/j.therap.2022.11.003. Epub 2022 Nov 25. Therapie. 2023. PMID: 36577617 French. No abstract available.
Antipsychotics and risk of QT prolongation: a pharmacovigilance study.
Bordet C, Garcia P, Salvo F, Touafchia A, Galinier M, Sommet A, Montastruc F. Bordet C, et al. Among authors: salvo f. Psychopharmacology (Berl). 2023 Jan;240(1):199-202. doi: 10.1007/s00213-022-06293-4. Epub 2022 Dec 14. Psychopharmacology (Berl). 2023. PMID: 36515735
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration.
Fusaroli M, Salvo F, Begaud B, AlShammari TM, Bate A, Battini V, Brueckner A, Candore G, Carnovale C, Crisafulli S, Cutroneo PM, Dolladille C, Drici MD, Faillie JL, Goldman A, Hauben M, Herdeiro MT, Mahaux O, Manlik K, Montastruc F, Noguchi Y, Norén GN, Noseda R, Onakpoya IJ, Pariente A, Poluzzi E, Salem M, Sartori D, Trinh NTH, Tuccori M, van Hunsel F, van Puijenbroek E, Raschi E, Khouri C. Fusaroli M, et al. Among authors: salvo f. Drug Saf. 2024 Jun;47(6):585-599. doi: 10.1007/s40264-024-01423-7. Epub 2024 May 7. Drug Saf. 2024. PMID: 38713347 Free PMC article.
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement.
Fusaroli M, Salvo F, Begaud B, AlShammari TM, Bate A, Battini V, Brueckner A, Candore G, Carnovale C, Crisafulli S, Cutroneo PM, Dolladille C, Drici MD, Faillie JL, Goldman A, Hauben M, Herdeiro MT, Mahaux O, Manlik K, Montastruc F, Noguchi Y, Norén GN, Noseda R, Onakpoya IJ, Pariente A, Poluzzi E, Salem M, Sartori D, Trinh NTH, Tuccori M, van Hunsel F, van Puijenbroek E, Raschi E, Khouri C. Fusaroli M, et al. Among authors: salvo f. Drug Saf. 2024 Jun;47(6):575-584. doi: 10.1007/s40264-024-01421-9. Epub 2024 May 7. Drug Saf. 2024. PMID: 38713346 Free PMC article.
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis.
Raschi E, Salvo F, Bate A, De Ponti F, Poluzzi E, Tuccori M, van Puijenbroek E, Joshi N, Khouri C. Raschi E, et al. Among authors: salvo f. Drug Saf. 2024 Jul;47(7):601-605. doi: 10.1007/s40264-024-01419-3. Epub 2024 Mar 18. Drug Saf. 2024. PMID: 38498258 No abstract available.
Interpretation of Pharmacovigilance Disproportionality Analyses.
Khouri C, Fusaroli M, Salvo F, Raschi E. Khouri C, et al. Among authors: salvo f. Clin Pharmacol Ther. 2023 Oct;114(4):745-746. doi: 10.1002/cpt.2951. Epub 2023 May 30. Clin Pharmacol Ther. 2023. PMID: 37248829 No abstract available.
Will the future of pharmacovigilance be more automated?
Salvo F, Micallef J, Lahouegue A, Chouchana L, Létinier L, Faillie JL, Pariente A. Salvo F, et al. Expert Opin Drug Saf. 2023 Jul-Dec;22(7):541-548. doi: 10.1080/14740338.2023.2227091. Epub 2023 Jul 12. Expert Opin Drug Saf. 2023. PMID: 37435796 Review.
159 results